In Nigeria, thousands of men are living with a disease the world has taught them to believe they cannot have. Male breast cancer, rare in the global north but accounting for up to fifteen percent of cases in sub-Saharan Africa, remains almost entirely absent from public health messaging—leaving men without the language, the permission, or the awareness to seek help until it is often too late. Medical experts are now calling for a fundamental rethinking of who breast cancer campaigns speak to, arguing that silence itself has become a clinical risk factor.
Male breast cancer: Nigeria's overlooked health crisis demands urgent awareness
Men with male breast cancer experience delayed diagnosis and higher mortality rates due to lack of awareness, with survival rates comparable to women only when caught at early stages.
Men feel strong. They ignore warning signs.
Mark
Why has male breast cancer been so invisible in Nigeria's health messaging?
Mimi
Because globally it's rare—only about one percent of cases—so it's been easy to ignore. But in parts of Africa, including Nigeria, the rates are much higher. We've built all our awareness around women, so men don't see themselves in the conversation. They don't know it's possible.
Mark
What happens when a man finds a lump but doesn't know breast cancer can affect him?
Mimi
He waits. He assumes it's nothing. By the time he gets checked—if he gets checked—the cancer has often advanced. That delay is what kills. The disease itself isn't necessarily more aggressive in men, but late detection is.
Mark
Are there specific genetic risks that make some men more vulnerable?
Mimi
Yes. BRCA mutations, Klinefelter syndrome, liver disease, testicular problems. Some of these are hereditary, which means families can be screened. But you have to know to look for them first.
Mark
What would actually change men's behavior—getting them to check themselves or see a doctor?
Mimi
Visibility. Men need to see themselves represented in the messaging. They need to hear from other men, in spaces where men gather. A brief talk at a mosque or workplace about checking your chest could save lives. Right now, that conversation isn't happening.
Mark
If a man is diagnosed early, does he have a real chance?
Mimi
Absolutely. Stage one or two survival rates are comparable to women. The problem is almost no one catches it that early because no one's looking for it in men.
El Pulso
- A Nigerian man watched a lump grow near his nipple for three years because every public health message he had ever encountered told him breast cancer was not his disease.
- Sub-Saharan African men develop breast cancer at rates five to fifteen times higher than their European counterparts, yet remain almost entirely excluded from clinical trials, treatment research, and awareness campaigns.
- Late-stage diagnosis is the norm for Nigerian men with breast cancer—not because the disease is more lethal in men, but because no one told them to look, and cultural expectations of male stoicism make waiting feel like strength.
- Oncologists are urging that breast cancer education move into workplaces, churches, mosques, and community centers, meeting men where they gather rather than waiting for them to arrive at hospitals already in crisis.
- When caught early, men survive breast cancer at rates comparable to women—making awareness not merely a matter of equity, but a direct and measurable intervention against preventable death.
In Nigeria, thousands of men are living with a disease the world has taught them to believe they cannot have. Male breast cancer, rare in the global north but accounting for up to fifteen percent of cases in sub-Saharan Africa, remains almost entirely absent from public health messaging—leaving men without the language, the permission, or the awareness to seek help until it is often too late. Medical experts are now calling for a fundamental rethinking of who breast cancer campaigns speak to, arguing that silence itself has become a clinical risk factor.
Gold Amopho's husband noticed a small bump near his nipple three years before anyone took it seriously. Breast cancer, every campaign had told him, was a woman's disease. So the lump grew, changed, and was ignored—until a nurse friend recognized the warning signs. By then, the cancer had advanced. Amopho has since become an unlikely advocate, carrying a message the public health system has largely failed to deliver: men get breast cancer too, and waiting can cost you your life.
Globally, male breast cancer accounts for roughly one percent of all cases. In sub-Saharan Africa, the picture is strikingly different. Hospital-based studies across Nigeria show rates ranging from eight to fifteen percent of all breast cancer diagnoses—five to fifteen times higher than in Europe. Researchers point to hepatitis B-related liver disease, schistosomiasis, and testicular conditions as possible contributors, though the exact mechanisms remain under study. What is not in doubt is that thousands of Nigerian men are affected, and most find out far too late.
Dr. Ademola Oyekan, a radiation oncologist at Lagos University Teaching Hospital, explains that because male breast cancer is globally rare, it has been chronically understudied. Men have been left out of clinical trials, and treatment protocols have largely borrowed from those designed for postmenopausal women. Yet the risk factors for men are specific and identifiable: BRCA2 and BRCA1 genetic mutations, Klinefelter syndrome—which raises risk by twenty to fifty times—liver cirrhosis, testicular disorders, obesity, and family history. Targeted screening is possible, but only if men and their doctors know to pursue it.
Dr. Kehinde Ololade names the symptoms men must never dismiss—lumps, nipple discharge, ulceration, swollen lymph nodes—and identifies a cultural force working against early detection: men are conditioned to feel invulnerable, to wait for pain, to wait for certainty. Dr. Anthony Gaius adds the sharpest clarification: men's survival rates are lower not because the disease is inherently more aggressive, but because men arrive at hospitals at stage three or four. Caught at stage one or two, their outcomes match women's.
All three oncologists converge on the same demand: breast cancer campaigns must begin speaking to men. The messaging must reach beyond hospitals into the spaces where men actually live—workplaces, places of worship, community centers, schools. Amopho's husband had no cultural permission to be concerned, no public health framework that included him. The oncologists are asking how many more men must wait in that same silence before the campaigns finally change.
Gold Amopho's husband noticed a small bump near his nipple three years ago. It looked like nothing—a pimple, maybe, something that would go away on its own. He didn't think much of it. Neither did anyone else around him. Breast cancer, after all, is a woman's disease. That's what the billboards say. That's what the October campaigns show. That's what the radio jingles teach. So the lump sat there, growing slowly, changing color, while a man who had no framework for understanding what was happening to his body simply lived with it. By the time Amopho convinced him to see a doctor—with help from a nurse friend who recognized something was wrong—the cancer had advanced. Now the couple is in treatment, and Amopho has become an unlikely messenger: men get breast cancer too, and waiting for pain, waiting for certainty, waiting for it to feel serious enough, can cost you your life.
The medical world has known this for decades, yet the public conversation has almost entirely excluded men. Globally, male breast cancer accounts for roughly one percent of all breast cancer cases. In Europe, the proportion holds steady at about one percent. But in sub-Saharan Africa, the numbers shift dramatically. Hospital-based studies across Nigeria show wide variation—nine percent of breast cancers in Zaria, 8.6 percent in Jos, eight percent in the eastern region, lower percentages in the southwest—but the pattern is clear: African men are getting breast cancer at rates five to fifteen times higher than their European counterparts. Researchers point to factors like hepatitis B-related liver disease, schistosomiasis, testicular conditions, and how patients are referred to oncology centers. The exact mechanisms remain unclear. What is certain is that thousands of Nigerian men are affected, and most discover it far too late.
Dr. Ademola Oyekan, a radiation and clinical oncologist at Lagos University Teaching Hospital, traces the silence to simple mathematics. Because male breast cancer is rare globally, it has been understudied and largely ignored. Men have been underrepresented in clinical trials. Treatment protocols have simply borrowed from what works for postmenopausal women. The risk factors, though, are distinct. Age matters—genetic mutations accumulate over time. Genetic mutations themselves matter enormously: BRCA2 carries the highest inherited risk, but BRCA1, PALB2, CHEK2, and ATM mutations also elevate danger. Klinefelter syndrome, a chromosomal condition where men have an extra X chromosome and elevated estrogen, increases risk by twenty to fifty times. Testicular disorders, liver cirrhosis, obesity, and even exogenous estrogen use all play a role. Family history matters. The list is long and specific, which means screening can be targeted—but only if men and their doctors know to look.
For men at high risk, Oyekan recommends they become familiar with how their breasts normally look and feel, then report any change immediately. Those carrying BRCA mutations or with strong family histories should see a physician every six to twelve months starting at age thirty-five. Genetic counseling is essential for families with a known mutation or multiple relatives with breast, ovarian, pancreatic, or prostate cancer. High-risk men should also undergo prostate cancer screening and consider pancreatic surveillance. Lifestyle changes—maintaining healthy weight, exercising regularly, reducing alcohol, avoiding unnecessary estrogen exposure—matter. When cancer is found, treatment requires a multidisciplinary approach: surgery, chemotherapy, hormonal therapy, radiotherapy, targeted therapy. Male breast tissue is sparse, so mastectomy rather than breast-conserving surgery is typical.
Dr. Kehinde Ololade, a clinical oncologist at Jakaranda Cancer Care, points to symptoms men should never ignore: a small swelling or lump, ulceration, bloody discharge from the nipple, swollen lymph nodes in the armpit, changes in breast size. He also names a cultural barrier that may be the most powerful of all: men feel strong. They ignore warning signs. They don't think breast cancer applies to them. Dr. Anthony Gaius adds a sobering fact: survival rates for men with breast cancer are generally lower than for women, but not because the disease is inherently more lethal. The difference is timing. When caught at stage one or two, men survive at rates comparable to women. But because awareness is nearly absent, men arrive at hospitals with stage three or four disease. The biology can be more aggressive in some cases, but the primary killer is delay.
All three oncologists made the same plea: public health campaigns must include men. Breast cancer education cannot remain a women's issue if men are getting sick and dying from it. The messaging needs to reach beyond hospitals into workplaces, churches, mosques, community centers—places where men actually gather. Community health workers need to talk directly to men about checking their chests. Schools need to teach that breast cancer is a human disease, not a gendered one. The media needs to show men in the awareness materials. Amopho's husband waited three years because he had no language for what was happening, no cultural permission to be concerned, no public health message that included him. The oncologists are asking: how many more men will wait before we change that?
Citas Notables
If you notice anything odd around your breast area—a lump, swelling, or change in color—go for a checkup. Male breast cancer exists, and early detection can save you.— Gold Amopho, whose husband was diagnosed with male breast cancer
The rate of survival for men with breast cancer is generally lower compared to women, largely because of late presentation. When diagnosed early, survival rates for men are comparable to women.— Dr. Anthony Gaius, oncologist
Quieres la nota completa?
Lee el original en The Sun Nigeria ↗
Health & Medicine